Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Esophageal Squamous Cell Carcinoma”

100 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 100 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04666090
What this trial is testing

Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant Therapy
Second Affiliated Hospital, School of Medicine, Zhejiang University 42
Testing effectiveness (Phase 2)Study completedNCT00072033
What this trial is testing

Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer

Who this might be right for
Esophageal Cancer
Swiss Cancer Institute 66
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05833971
What this trial is testing

Cadonilimab in Combination With Chemotherapy for Locally Advaced Esophageal Squamous Cell Carcinoma

Who this might be right for
Resectable Esophageal Squamous Cell CarcinomaNeoadjuvant Therapy
Guangzhou Institute of Respiratory Disease 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06861894
What this trial is testing

Active Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Zhigang Li 164
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06508229
What this trial is testing

Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Harbin Medical University 65
Testing effectiveness (Phase 2)UnknownNCT05828381
What this trial is testing

Envafolimab Combined With Abraxane and Cisplatinas as Neoadjuvant Treatment for Resectable Esophageal Cancer

Who this might be right for
Immunotherapy;Envafolimab; Esophageal Cancer
Fujian Medical University Union Hospital 33
Large-scale testing (Phase 3)Study completedNCT00047112
What this trial is testing

Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Federation Francophone de Cancerologie Digestive 195
Testing effectiveness (Phase 2)UnknownNCT03946969
What this trial is testing

Sintilimab in Combination With Chemotherapy in Neoadjuvant Treatment of Potentially Resectable Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital with Nanjing Medical University 30
Large-scale testing (Phase 3)Looking for participantsNCT05547529
What this trial is testing

The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer

Who this might be right for
Esophageal Cancer
Blokhin's Russian Cancer Research Center 156
Testing effectiveness (Phase 2)UnknownNCT04215471
What this trial is testing

NeoAdjuvant Therapy With Immunoreagent (SHR-1316) for Resectable Oesophageal Squamous Cell carciNoma

Who this might be right for
Oesophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT00258297
What this trial is testing

Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By Surgery

Who this might be right for
Esophageal Cancer
University of Rochester 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06852456
What this trial is testing

QL1706 in Combination With Neoadjuvant Chemotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced, Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
Qilu Pharmaceutical Co., Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT00069953
What this trial is testing

Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Who this might be right for
Esophageal Cancer
Radiation Therapy Oncology Group 43
Not applicableEnrolling By InvitationNCT06475196
What this trial is testing

Prospective Cohort Study of Neoadjuvant Therapy With Sintilimab (PD-1 Inhibitor) Combined With Chemotherapy in Resectable ESCC

Who this might be right for
Resectable Esophageal Squamous Cell Carcinoma
Tang-Du Hospital 90
Testing effectiveness (Phase 2)Looking for participantsNCT06663059
What this trial is testing

Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles Study

Who this might be right for
Esophageal Cancer
Tang-Du Hospital 80
Testing effectiveness (Phase 2)UnknownNCT04006041
What this trial is testing

Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma by AJCC V8 StageResectable Esophageal Cancer
Jianhua Fu 44
Testing effectiveness (Phase 2)Looking for participantsNCT06056336
What this trial is testing

Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant ChemoimmunotherapyAdjuvant Therapy
Guo Xufeng 73
Testing effectiveness (Phase 2)Looking for participantsNCT07385001
What this trial is testing

A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaIvonescimabNeoadjuvant
Tang-Du Hospital 45
Not applicableLooking for participantsNCT07054086
What this trial is testing

Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Shanghai Zhongshan Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06599775
What this trial is testing

Study of Adebrelimab With Chemotherapy, Endoscopy and Sequential Chemoradiotherapy In Inoperable Esophageal Cancer

Who this might be right for
Resectable Esophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital 42
Load More Results